Integration of Buprenorphine into HIV Primary Care Settings: Tools from the Integrating HIV Innovative Practices Program
HRSA HIV/AIDS Bureau (HAB)
This package of training and implementation tools was developed to assist Ryan White and other HIV clinics to integrate buprenorphine programs in primary care settings.
Tool for HIV/AIDS clinical programs who are considering integrating opioid addiction treatment using buprenorphine. Chapters cover background and rationale, lessons learned from the HRSA SPNS Initiative, and information for prescribers and clinic managers.
This provides physicians the information needed to educate clinic staff and stakeholders on integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care. It also provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.
Webinar: Clinical Aspects of Buprenorphine Therapy
In this webinar clinicians provide a definition of buprenorphine. They describe how it works, what opioids do to the brain, and how buprenorphine differs from methadone.
Also outlined are the following:
- Important drug-drug interactions
- The concept of precipitated withdrawal and how to recognize it
- How to determine patient eligibility
- Clinical aspects of working with opioid-addicted people living with HIV
Webinar: Training and Integration
This webinar introduced providers to the SPNS Buprenorphine Initiative, its findings, its synergy with the National HIV/AIDS Strategy, and provided an overview of opioid use and HIV.
FAQ and Peer Discussion
Find quick answers to common questions, or pose questions to the IHIP team.